Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22 (382 d 14:40 ago) – Posting: # 20812
Views: 3,133

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

Activity
 Admin contact
21,232 posts in 4,427 threads, 1,482 registered users;
online 7 (1 registered, 6 guests [including 3 identified bots]).
Forum time: Thursday 08:02 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5